US Stocks

DermTech, Inc.

DermTech, Inc. is a diagnostic company specializing in non-invasive genomics tests that can diagnose skin cancer, inflammatory diseases, and aging-related conditions in the United States. Their DermTech Melanoma Test (DMT) a gene expression-based test helps detect genomic atypia early on and rule out the need for surgical biopsy. Additionally, the company is also developing other diagnostic products and offering electronic health information services.